Moderna raises 2022 vaccine sales forecast to $18.5 billion -Breaking
[ad_1]
© Reuters. FILE PHOTO – People pose for a photo with a syringe and needle in front of the Moderna logo. Illustration taken on December 11, 2021. REUTERS/Dado Ruvic(Reuters) – Moderna (NASDAQ:) Inc announced Monday that it expects to sell about $18.5 Billion in 2022, primarily from COVID-19 contracts. It also plans to purchase about $3.5 Billion for possible additional orders.
According to the company, its 2022 revenues could range from $17 billion up to $22 million as predicted in November.
Disclaimer: Fusion MediaThis website does not provide accurate and current data. CFDs include stocks, indexes and futures. Prices are provided not by the exchanges. Market makers provide them. Therefore, prices can be inaccurate and differ from actual market prices. These prices should not be used for trading. Fusion Media does not accept any liability for trade losses that you may incur due to the use of these data.
Fusion MediaFusion Media and anyone associated with it will not assume any responsibility for losses or damages arising from the use of this information. This includes data including charts and buy/sell signal signals. Trading the financial markets is one of most risky investment options. Please make sure you are fully aware about the costs and risks involved.
[ad_2]